THE COST-EFFECTIVENESS OF HEPATITIS C TREATMENTS IN TREATMENT NAIVE GENOTYPE 1 PATIENTS

被引：0
|
作者：
McGinnis, J. J. [1 ]
Hay, J. W. [1 ]
机构：
[1] Univ So Calif, Los Angeles, CA USA
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 03期
关键词：
D O I：
10.1016/j.jval.2014.03.1598
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PIN55
引用
收藏
页码：A274 / A274
页数：1
相关论文
共 50 条
  • [21] THE COST EFFECTIVENESS OF A NOVEL HIGH PRICED COMBINATION THERAPY FOR HEPATITIS C IN TREATMENT NAIVE GENOTYPE 1 INFECTED PATIENTS
    McGinnis, J. J.
    Hay, J. W.
    VALUE IN HEALTH, 2015, 18 (03) : A238 - A239
  • [22] Cost-effectiveness of sofosbuvir in the treatment of patients with hepatitis C
    Leleu, H.
    Blachier, M.
    Rosa, I.
    JOURNAL OF VIRAL HEPATITIS, 2015, 22 (04) : 376 - 383
  • [23] COST-EFFECTIVENESS OF TELAPREVIR COMBINATION THERAPY COMPARED TO PEGINTERFERON WITH RIBAVIRIN ALONE FOR NAIVE AND TREATMENT EXPERIENCED PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS C IN POLAND
    Kaczor, M. P.
    Wojcik, R.
    Pawlik, D.
    Skrzekowska-Baran, I
    Tronczynski, K.
    VALUE IN HEALTH, 2013, 16 (07) : A359 - A360
  • [24] Cost-effectiveness of Sofosbuvir plus Ledipasvir Antiviral Treatment for Elderly Patients with Chronic Hepatitis C Genotype 1
    Ciaccio, Antonio
    Cortesi, Paolo
    Bellelli, Giuseppe
    Rota, Matteo
    Rota, Monica
    Mantovani, Lorenzo G.
    Annoni, Giorgio
    Strazzabosco, Mario
    HEPATOLOGY, 2015, 62 : 919A - 919A
  • [25] Cost-Effectiveness of Genotype 1 Chronic Hepatitis C Virus Treatments in Patients Coinfected with Human Immunodeficiency Virus in the United States
    Sammy Saab
    Suchin Virabhak
    Hélène Parisé
    Scott Johnson
    Alice Wang
    Derek Misurski
    Yuri Sanchez Gonzalez
    Timothy Juday
    Advances in Therapy, 2016, 33 : 1316 - 1330
  • [26] Cost-Effectiveness of Genotype 1 Chronic Hepatitis C Virus Treatments in Patients Coinfected with Human Immunodeficiency Virus in the United States
    Saab, Sammy
    Virabhak, Suchin
    Parise, Helene
    Johnson, Scott
    Wang, Alice
    Misurski, Derek
    Gonzalez, Yuri Sanchez
    Juday, Timothy
    ADVANCES IN THERAPY, 2016, 33 (08) : 1316 - 1330
  • [27] Cost-effectiveness of strategy-based approach to treatment of genotype 1 chronic hepatitis C
    Zhao, Ying Jiao
    Khoo, Ai Leng
    Lin, Liang
    Teng, Monica
    Koh, Calvin J.
    Lim, Seng Gee
    Lim, Boon Peng
    Dan, Yock Young
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 (09) : 1628 - 1637
  • [28] COST-EFFECTIVENESS OF LEDIPASVIR/SOFOSBUVIR FOR THE TREATMENT OF GENOTYPE 1 OR 4 CHRONIC HEPATITIS C IN SCOTLAND
    Dillon, J.
    Treharne, C.
    Howells, R.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S635 - S635
  • [29] COST-EFFECTIVENESS OF BOCEPREVIR THERAPY IN ADULT PATIENTS WITH CHRONIC HEPATITIS C (HCV) GENOTYPE 1
    Mernagh, P.
    Feng, J.
    Del Cuore, M.
    VALUE IN HEALTH, 2013, 16 (03) : A94 - A94
  • [30] Cost-effectiveness analysis of different protease inhibitors-based strategies in the treatment of naive patients with genotype 1 chronic hepatitis C (G1-CHC)
    Papatheodoridis, George V.
    Arzoumanidou, Daphne
    HEPATOLOGY, 2012, 56 : 1014A - 1014A
12345